Dr. Lisa Sterman holds up a Truvada pill at her office in San Francisco in May. Even before the Food and Drug Administration's approval, Sterman had prescribed Truvada for about a dozen patients at high risk for developing AIDS.
The Food and Drug Administration has given the first OK for a drug to prevent HIV infection.
The daily pill Truvada, made by Gilead Sciences, combines two medicines that inhibit the reproduction of HIV. It's been a mainstay in the treatment of HIV/AIDS for years, and as of today is an approved option for reducing the risk of HIV infection for people at high risk.
"Thirty years ago, a positive HIV status was considered a death sentence. As treatments for the disease have advanced over the past three decades, we're wondering how younger people view the disease today."
Hundreds of people e-mailed and commented with their reactions. We also gathered reactions from young folks we met on the street.
Crystal Roberts-Lee has lived a tough life, and her HIV has, in some ways, been the least of her worries.
She was addicted to heroin and cocaine. Her daughter went to prison. A scorpion tattoo crawling across her neck marks the day her husband died from AIDS. Now, at 59, Roberts-Lee is the healthiest she has ever been.
"After I take my medicine, it's just a normal day for me," she says. "I go on with whatever I have to do. If I'm just out and about, I feel like I'm just like the next person."